Alexey Simakov

5PUBLICATIONS
16CO-AUTHORS
Molecular targetsBiomolecular modelling and designBiologically active moleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 14, 2025
Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer's Disease Treatment.

Alexey Simakov, Stecy Chhor, Lhassane Ismaili

|Aug 29, 2024
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors.

Rim Malek, Kinga Sałat, Perle Totoson

|Jan 23, 2024
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties.

Irene Pachón-Angona, Paul J Bernard, Alexey Simakov

|Jun 10, 2023
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.

Imen Dakhlaoui, Paul J Bernard, Diana Pietrzak

|Jan 08, 2023
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation.

Rim Malek, Alexey Simakov, Audrey Davis

Pageof 1

Frequent Collaborators

5 joint publications

Lhassane Ismaili

4 joint publications

Helene Martin

3 joint publications

Krzysztof Jozwiak

1 joint publications

Audrey Davis